Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Ann Plast Surg ; 92(1S Suppl 1): S65-S69, 2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-38170985

RESUMEN

ABSTRACT: The management of critical limb trauma is challenging because limb salvage is preferable to amputation. For upper limb reconstruction, the surgical restoration of functionality, and appearance, a multidisciplinary approach is needed. We report the case of an extensive composite tissue defect of the forearm caused by a machine-crushing injury that was repaired by a flow-through chimeric anterolateral thigh flap with a vascularized fibular graft. Reconstruction was performed as a single-stage procedure; no complications occurred, and both functional and aesthetic outcomes were satisfactory.


Asunto(s)
Procedimientos de Cirugía Plástica , Traumatismos de los Tejidos Blandos , Humanos , Muslo/cirugía , Antebrazo/cirugía , Colgajos Quirúrgicos/cirugía , Extremidad Superior/cirugía , Traumatismos de los Tejidos Blandos/cirugía
2.
J Plast Reconstr Aesthet Surg ; 95: 368-376, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38986311

RESUMEN

INTRODUCTION: Considerable research has been carried out on the postoperative benefits of extended antibiotic prophylaxis (EAP) in different surgical contexts, generating various results regarding its effectiveness. Some studies indicate positive outcomes, whereas others indicate no significant advantages. Our approach involves conducting a comprehensive systematic review and meta-analysis to provide a more nuanced understanding of the role of extended antibiotic use because of the lack of a consistent consensus. METHODS: A thorough search of the Cochrane Library, Embase, and MEDLINE electronic databases was conducted to identify relevant studies. The metafor package in R software was used for meta-analysis. We collected risk ratios (RRs) for surgical site infection (SSI) in the EAP versus non-EAP groups from the included studies to assess the effects of EAP on reducing the risk of SSI. The meta-analysis used a random-effects model, and effect sizes were presented with their corresponding 95% confidence intervals (CIs). RESULTS: Fourteen studies, involving 12,572 patients who underwent implant-based reconstruction postmastectomy, were included. Pooling the results of the studies that used EAP until drain removal revealed no protective effect of EAP against SSI risk (RR = 0.84; 95% CI: 0.60-1.18). Similarly, our analysis revealed no significant benefit of EAP in studies where EAP was not contingent on drain removal (RR = 0.70; 95% CI: 0.46-1.07). CONCLUSIONS: EAP administration did not decrease the incidence of SSI in individuals undergoing implant-based breast reconstruction surgery postmastectomy.


Asunto(s)
Profilaxis Antibiótica , Implantación de Mama , Infección de la Herida Quirúrgica , Humanos , Profilaxis Antibiótica/métodos , Infección de la Herida Quirúrgica/prevención & control , Femenino , Implantación de Mama/métodos , Implantación de Mama/efectos adversos , Antibacterianos/administración & dosificación , Implantes de Mama/efectos adversos , Mamoplastia/métodos , Mamoplastia/efectos adversos , Mastectomía , Neoplasias de la Mama/cirugía
3.
Anticancer Res ; 40(3): 1631-1636, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32132067

RESUMEN

Lymphangioma insults in adults are uncommon and the occurrence in the oropharynx is extremely rare. Although disease history and clinical symptoms may help in distinguishing it from malignant tumors, the pathophysiology of lymphangioma via histological examinations should be established for convenient and precise diagnosis. We present a 20-year-old male with lymphangioma in the right oropharynx, and the multiple-angle examination and treatment plan used. The case further emphasizes the need to consider lymphangioma in the differential diagnosis of an oropharyngeal mass. Awareness that lymphangioma can occur in adults is important for its proper management, which includes complete surgical removal to prevent recurrence.


Asunto(s)
Linfangioma/diagnóstico , Orofaringe/patología , Adulto , Humanos , Linfangioma/patología , Masculino , Adulto Joven
4.
Sci Rep ; 10(1): 18635, 2020 10 29.
Artículo en Inglés | MEDLINE | ID: mdl-33122743

RESUMEN

Evidence shows that chronic rhinosinusitis (CRS) is associated with prior presence of autoimmune diseases; however, large-scale population-based studies in the literature are limited. We conducted a population-based case-control study investigating the association between CRS and premorbid autoimmune diseases by using the National Health Insurance Research Database in Taiwan. The CRS group included adult patients newly diagnosed with CRS between 2001 and 2013. The date of diagnosis was defined as the index date. The comparison group included individuals without CRS, with 1:4 frequency matching for gender, age, and index year. Premorbid diseases were forward traced to 1996. Univariate and multivariate logistic regression was performed to estimate odds ratios (ORs) and 95% confidence intervals. The CRS group consisted of 30,611 patients, and the comparison group consisted of 122,444 individuals. Patients with CRS had a higher significant association with premorbid autoimmune diseases (adjusted OR 1.39 [1.28-1.50]). Specifically, patients with CRS had a higher significant association with ankylosing spondylitis, polymyositis, psoriasis, rheumatoid arthritis, sicca syndrome, and systemic lupus erythematosus (adjusted OR 1.49 [1.34-1.67], 3.47 [1.12-10.8], 1.22 [1.04-1.43], 1.60 [1.31-1.96], 2.10 [1.63-2.72], and 1.69 [1.26-2.25]). In subgroup analysis, CRS with and without nasal polyps demonstrated a significant association with premorbid autoimmune diseases (adjusted OR 1.34 [1.14-1.58] and 1.50 [1.38-1.62]). In addition, CRS with fungal and non-fungal infections also demonstrated a significant association with premorbid autoimmune diseases (adjusted OR 2.02 [1.72-2.49] and 1.39 [1.28-1.51]). In conclusion, a significant association between CRS and premorbid autoimmune diseases has been identified. These underlying mechanisms need further investigation.


Asunto(s)
Enfermedades Autoinmunes/complicaciones , Vigilancia de la Población , Sinusitis/complicaciones , Adulto , Estudios de Casos y Controles , Enfermedad Crónica , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Adulto Joven
5.
In Vivo ; 34(1): 261-265, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31882487

RESUMEN

BACKGROUND/AIM: Solitary extramedullary plasmacytoma (SEP) is a rare, malignant plasma-cell tumor, which mainly occurs in the head and neck regions. Globally the disease has been rarely happening up to 2019, with only about ten papers focused on SEP cases reported in English. Thus, a literature collectively reviewing the characteristics of the patients would be valuable. PATIENTS AND METHODS: We enrolled 10 SEP patients, and recorded their primary sites and the treatment modality, and analyzed their survival rates and outcomes. We also reviewed previous studies and compared their findings with ours. RESULTS: No gender or age disparity has been observed, and younger patients had a better local control with RT compared to surgery among our patients. CONCLUSION: Further investigations with more patients and long-time follow-up may provide more information for treatment determination and the recurrence and progression from SEP to MM.


Asunto(s)
Neoplasias de Cabeza y Cuello/patología , Recurrencia Local de Neoplasia/patología , Plasmacitoma/patología , Adulto , Anciano , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Neoplasias de Cabeza y Cuello/epidemiología , Neoplasias de Cabeza y Cuello/terapia , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/epidemiología , Recurrencia Local de Neoplasia/terapia , Plasmacitoma/epidemiología , Plasmacitoma/terapia , Pronóstico , Taiwán/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA